Drugs con­tain­ing nano­ma­te­ri­als: FDA fi­nal­izes 2017 guid­ance with sev­er­al changes

The FDA on Thurs­day fi­nal­ized a draft guid­ance from 2017 ex­plain­ing the prin­ci­ples and spe­cif­ic con­sid­er­a­tions for de­vel­op­ing drugs (bi­o­log­ics and gene ther­a­pies are ex­clud­ed) …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER